Tilray (TLRY) CEO on Potential US Cannabis Reclassification

Tilray Brands, Inc. (NASDAQ:TLRY) is one of the 7 Best Hemp Stocks To Buy Now.

On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) shares rose by around 10% after surging as much as 18% earlier, amid strong trading activity of more than 20 million shares. He said the move shows interest in a potential cannabis reclassification, stressing that it is important “for patients” and the larger business, not just the corporation. He noted that the corporation distributes cannabis in over 21 countries, producing more than $100 million globally and $200 million in Canada, as well as conducts research into medical applications such as cancer and epilepsy.

As per the CEO, Tilray Brands, Inc. (NASDAQ:TLRY) does not currently sell cannabis in the United States, explaining that the company has instead grown into beer and beverages. He said that reclassification would help collaboration with the FDA, using current research for approvals addressing medical conditions. Entering the US market could happen “within six months” if licenses are granted, he said, calling the prospect “tremendous” given the firm’s infrastructure and global experience.

Tilray (TLRY) CEO on Potential US Cannabis Reclassification

Tilray Brands, Inc. (NASDAQ:TLRY) is a consumer packaged goods firm. It focuses on medical cannabis research and the cultivation, processing, and global distribution of cannabis products. It operates in the cannabis, distribution, beverage, and wellness segments.

While we acknowledge the risk and potential of TLRY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TLRY and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.